Nutritrace

Sodium Molybdate Dihydrate, the active ingredient in NutriTrace, is a nutrition supplement presented as a intravenous solution for clinical use. It supports trace element balance and metabolic functions in patients requiring parenteral nutrition.

GNH USA supplies NutriTrace as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

NutriTrace is used in clinical nutrition to address deficiencies of trace elements that are essential for enzymatic activity and metabolic pathways. - Copper deficiency: helps restore normal copper‑dependent enzymatic functions. - Zinc deficiency: contributes to immune competence and protein synthesis. - Iron (ferrous) deficiency: supports hemoglobin formation. - Molybdenum and chromium supplementation: aids enzymes involved in sulfur‑amino‑acid metabolism and glucose regulation. - General parenteral nutrition: provides a balanced trace‑element profile for patients on long‑term IV nutrition.

Adverse reactions to NutriTrace are generally related to the individual trace elements and the intravenous route.

Common Side Effects: - Mild fever or chills during infusion. - Localized redness or irritation at the injection site. - Transient headache. - Nausea or mild gastrointestinal upset. - Slight elevation of liver enzymes.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Acute hemolysis or hemoglobinuria. - Significant electrolyte imbalance (e.g., copper overload). - Renal impairment secondary to metal accumulation. - Severe thrombophlebitis at the infusion site.

When using NutriTrace, clinicians should observe standard safety measures for intravenous trace‑element solutions. - Dose individualisation: adjust based on laboratory‑monitored trace‑element levels. - Renal function: assess before initiation and monitor periodically. - Hepatic function: check liver enzymes, especially with copper and iron components. - Compatibility: verify compatibility with other IV fluids and medications. - Monitoring: observe patients for signs of hypersensitivity during and after infusion. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

NutriTrace may interact with other medications or solutions that affect trace‑element status or metal metabolism.

Major Interactions (Avoid): - Chelating agents (e.g., deferoxamine, EDTA) that bind copper, iron or zinc and markedly reduce efficacy. - High‑dose vitamin C infusions that can increase iron absorption and risk of oxidative stress.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracyclines or fluoroquinolones that can chelate zinc and reduce its bioavailability. - Loop diuretics that increase urinary excretion of zinc and copper. - Parenteral lipid emulsions that may affect the stability of the trace‑element solution. - Blood products transfused concurrently, which can alter measured trace‑element levels.